← Eichor
Condition: Vte Venous Thromboembolism Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Vte Venous Thromboembolism

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Heat Shock Protein 47 in Thrombosis
Phase N/A · 2 location(s) · University of Aarhus · NCT06731673Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
NA · 1 location(s) · Scott C. Woller, MD · NCT06232551Pulsed Electromagnetic Field Therapy or Pneumatic Compression VTE Prophylaxis
Phase 4 · 1 location(s) · Science Valley Research Institute · NCT06958588Reducing Gastrointestinal Bleeding With Proton Pump Inhibitor Therapy in Acute Venous Thromboembolism
Phase 3 · 7 location(s) · Ottawa Hospital Research Institute · NCT06393868Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis
Phase 3 · 8 location(s) · Marc Blondon · NCT07140211Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery
Phase N/A · 1 location(s) · The First Hospital of Jilin University · NCT07439991Excretion of Rivaroxaban in Human Breast Milk
Phase 1 · 1 location(s) · Thomas Jefferson University · NCT06831474VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy
Phase 2/Phase 3 · 1 location(s) · Ottawa Hospital Research Institute · NCT05920343AQT90 FLEX D-dimer Clinical Sensitivity and Specificity
Phase N/A · 1 location(s) · Radiometer Medical ApS · NCT06749223VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratifi
Phase N/A · 1 location(s) · Johannes Gutenberg University Mainz · NCT02156401CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism
NA · 1 location(s) · China-Japan Friendship Hospital · NCT04211181Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis
Phase 4 · 1 location(s) · Ottawa Hospital Research Institute · NCT06603870External Validation of the CLOVER Score for Detecting Occult Cancer in Venous Thromboembolism Patients
Phase N/A · 12 location(s) · Infanta Leonor University Hospital · NCT07310693DOAC - Dosing Options in AntiCoagulation Prophylaxis
Phase 3 · 1 location(s) · University of Vermont · NCT07005024Pregnancy and Risk of Venous Thromboembolism
NA · 1 location(s) · Hospices Civils de Lyon · NCT03659708NOACs Use in AF or VTE (SUNSHINE Registry)
Phase N/A · 1 location(s) · Henan Provincial People's Hospital · NCT05378308Effects of Genomic Profiles on Thromboembolic Risk in Patients With Locally Advanced or Metastatic Non-small-cell Lung C
Phase N/A · 1 location(s) · University Of Perugia · NCT07288632Prediction of Venous Thrombosis During chemotherapy-the PINPOINT Study
Phase N/A · 3 location(s) · University of Dublin, Trinity College · NCT07196020AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Ra
NA · 1 location(s) · Vanderbilt University Medical Center · NCT06939803REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Particip
Phase 3 · 32 location(s) · Regeneron Pharmaceuticals · NCT07213778VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization
Phase 4 · 1 location(s) · Science Valley Research Institute · NCT06873321Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty
Phase 2 · 1 location(s) · University of Miami · NCT04295486RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing
Phase 3 · 37 location(s) · University Hospital, Angers · NCT06195540PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)
Phase 3 · 12 location(s) · Sunnybrook Health Sciences Centre · NCT03559114Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Canc
Phase 3 · 2 location(s) · Regeneron Pharmaceuticals · NCT07493304Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee Arthroplasty
Phase 2 · 1 location(s) · Livzon Pharmaceutical Group Inc. · NCT06963320Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is
Phase 3 · 18 location(s) · Regeneron Pharmaceuticals · NCT07430956Early Exercise-Based Rehabilitation in Patients Hospitalized for Acute Pulmonary Embolism
NA · 6 location(s) · Insel Gruppe AG, University Hospital Bern · NCT07143539Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies
NA · 1 location(s) · Medical University of Gdansk · NCT07270263Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eA
NA · 1 location(s) · Brigham and Women's Hospital · NCT03728166
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.